Wegovy prescribing information states that the drug delays gastric emptying, has been associated with gastrointestinal adverse reactions that are sometimes severe, and is not recommended in patients with severe gastroparesis
How to Decide Between Ipamorelin, CJC-1295, or Both Heres a quick guide to help you think about your options: Choose Ipamorelin if your focus is fat loss, recovery, or better sleep
GLP-1 Receptor Activation: Suppresses appetite through hypothalamic pathways Slows gastric emptying Enhances insulin secretion GIP Receptor Activation: Amplifies GLP-1 satiety effects Improves insulin sensitivity May directly affect fat cell metabolism Glucagon Receptor Activation: Increases energy expenditure (metabolic rate) Promotes fat breakdown (lipolysis) May prevent metabolic adaptation The Advantage: Single molecule means simpler manufacturing, potentially easier regulatory approval, and all three pathways activated with every dose
The dose is usually administered on the same day each week, following a gradual dose-escalation schedule determined by the clinical trial protocol
In the STEP 1 extension, participants regained a mean of about two-thirds of prior weight loss one year after stopping semaglutide and structured lifestyle support
Both medications help with weight loss, but they work in different ways and have different benefits